Cargando…

Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening

BACKGROUND -: Fas ligand is a cytotoxic effector molecule of T and NK cells which is characterized by an intracellular N-terminal polyproline region that serves as a docking site for SH3 and WW domain proteins. Several previously described Fas ligand-interacting SH3 domain proteins turned out to be...

Descripción completa

Detalles Bibliográficos
Autores principales: Voss, Matthias, Lettau, Marcus, Janssen, Ottmar
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763855/
https://www.ncbi.nlm.nih.gov/pubmed/19807924
http://dx.doi.org/10.1186/1471-2172-10-53
_version_ 1782173043160776704
author Voss, Matthias
Lettau, Marcus
Janssen, Ottmar
author_facet Voss, Matthias
Lettau, Marcus
Janssen, Ottmar
author_sort Voss, Matthias
collection PubMed
description BACKGROUND -: Fas ligand is a cytotoxic effector molecule of T and NK cells which is characterized by an intracellular N-terminal polyproline region that serves as a docking site for SH3 and WW domain proteins. Several previously described Fas ligand-interacting SH3 domain proteins turned out to be crucial for the regulation of storage, expression and function of the death factor. Recent observations, however, indicate that Fas ligand is also subject to posttranslational modifications including shedding and intramembrane proteolysis. This results in the generation of short intracellular fragments that might either be degraded or translocate to the nucleus to influence transcription. So far, protein-protein interactions that specifically regulate the fate of the intracellular fragments have not been identified. RESULTS -: In order to further define the SH3 domain interactome of the intracellular region of Fas ligand, we now screened a human SH3 domain phage display library. In addition to known SH3 domains mediating binding to the Fas ligand proline-rich domain, we were able to identify a number of additional SH3 domains that might also associate with FasL. Potential functional implications of the new binding proteins for the death factor's biology are discussed. For Tec kinases and sorting nexins, the observed interactions were verified in cellular systems by pulldown experiments. CONCLUSION -: We provide an extended list of putative Fas ligand interaction partners, confirming previously identified interactions, but also introducing several novel SH3 domain proteins that might be important regulators of Fas ligand function.
format Text
id pubmed-2763855
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27638552009-10-20 Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening Voss, Matthias Lettau, Marcus Janssen, Ottmar BMC Immunol Research Article BACKGROUND -: Fas ligand is a cytotoxic effector molecule of T and NK cells which is characterized by an intracellular N-terminal polyproline region that serves as a docking site for SH3 and WW domain proteins. Several previously described Fas ligand-interacting SH3 domain proteins turned out to be crucial for the regulation of storage, expression and function of the death factor. Recent observations, however, indicate that Fas ligand is also subject to posttranslational modifications including shedding and intramembrane proteolysis. This results in the generation of short intracellular fragments that might either be degraded or translocate to the nucleus to influence transcription. So far, protein-protein interactions that specifically regulate the fate of the intracellular fragments have not been identified. RESULTS -: In order to further define the SH3 domain interactome of the intracellular region of Fas ligand, we now screened a human SH3 domain phage display library. In addition to known SH3 domains mediating binding to the Fas ligand proline-rich domain, we were able to identify a number of additional SH3 domains that might also associate with FasL. Potential functional implications of the new binding proteins for the death factor's biology are discussed. For Tec kinases and sorting nexins, the observed interactions were verified in cellular systems by pulldown experiments. CONCLUSION -: We provide an extended list of putative Fas ligand interaction partners, confirming previously identified interactions, but also introducing several novel SH3 domain proteins that might be important regulators of Fas ligand function. BioMed Central 2009-10-06 /pmc/articles/PMC2763855/ /pubmed/19807924 http://dx.doi.org/10.1186/1471-2172-10-53 Text en Copyright © 2009 Voss et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Voss, Matthias
Lettau, Marcus
Janssen, Ottmar
Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening
title Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening
title_full Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening
title_fullStr Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening
title_full_unstemmed Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening
title_short Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening
title_sort identification of sh3 domain interaction partners of human fasl (cd178) by phage display screening
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763855/
https://www.ncbi.nlm.nih.gov/pubmed/19807924
http://dx.doi.org/10.1186/1471-2172-10-53
work_keys_str_mv AT vossmatthias identificationofsh3domaininteractionpartnersofhumanfaslcd178byphagedisplayscreening
AT lettaumarcus identificationofsh3domaininteractionpartnersofhumanfaslcd178byphagedisplayscreening
AT janssenottmar identificationofsh3domaininteractionpartnersofhumanfaslcd178byphagedisplayscreening